4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-16-121465
Chief Executive Officer bought 2,125 shares at $2.40 ($5,100)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-05-18 | Purchase : show line 1 in the form | +2,125 | $2.40 | $5,100 | 9,990 | D |
| Open-market purchases · 2,125 sh · avg $2.40 · $5,100 | ||||||
Loading xslF345X03/doc4.xml…